Search

Your search keyword '"Lavorini F"' showing total 281 results

Search Constraints

Start Over You searched for: Author "Lavorini F" Remove constraint Author: "Lavorini F"
281 results on '"Lavorini F"'

Search Results

1. Suboptimal Peak Inspiratory Flow and Critical Inhalation Errors are Associated with Higher COPD-Related Healthcare Costs

2. A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD

3. The Burden of Self-Reported Rhinitis and Associated Risk for Exacerbations with Moderate-Severe Asthma in Primary Care Patients

4. The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes

5. Patients’ perspectives and preferences in the choice of inhalers: the case for Respimat® or HandiHaler&reg

6. The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes [Corrigendum]

7. Switching treatments in COPD: implications for costs and treatment adherence

12. Successful Use of Monoclonal and Antiviral Therapy in Immunocompromised Patients With Persistent and/or Relapsing COVID-19

13. Identifying critical inhalation technique errors in Dry Powder Inhaler use in patients with COPD based on the association with health status and exacerbations: findings from the multi-country cross-sectional observational PIFotal study.

14. Lung vascular changes as biomarkers of severity in systemic sclerosis-associated interstitial lung disease

15. Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN)

17. Phenotypes of post covid interstitial lung disease; clinical, radiological, and pathological correlations.

18. Sufficient inspiratory effort for a Dry Powder Inhaler - do we have to measure it, or can we observe it? Post hoc analysis of the PIFotal study

20. Role of BAL in COVID-19 patients: a prospective multicentre study

22. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

23. Pulmonary Edema

24. The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19

28. Switching to the Dry-Powder Inhaler Easyhaler®: A Narrative Review of the Evidence

29. Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9)

31. OP0181 FUNCTIONAL CUT-OFFS TO DISTINGUISH PULMONARY VASCULAR AND PARENCHYMAL INVOLVEMENT IN SYSTEMIC SCLEROSIS (SSC): A QUANTITATIVE ANALYSIS OF IMAGING FEATURES AT CHEST COMPUTED TOMOGRAPHY (CT)

32. SAT0553 QUANTITATIVE ANALYSIS OF IMAGING FEATURES AT CHEST CT OF PULMONARY ARTERIAL AND VENOUS COMPONENTS IN SYSTEMIC SCLEROSIS-INTERSTITIAL LUNG DISEASE (SSc-ILD).

37. Spirometric assessment of emphysema presence and severity as measured by quantitative CT and CT-based radiomics in COPD

38. EP1.04-02 Predictors of Lung Toxicity in First Line Pembrolizumb for Advanced NSCLC: An Interim Analysis of PRELUTOX Study

39. Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax (R) compared with budesonide/formoterol Turbuhaler (R) in adult patients with asthma: the Easy Low Instruction Over Time (ELIOT) study

40. Inhaler technique mastery and maintenance in healthcare professionals trained on different devices

42. Erratum to: Safety Considerations of Inhaled Corticosteroids in the Elderly(Drugs Aging, (2014), 31, 7987-796, DOI 10.1007/s40266-014-0213-1)

44. Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA(2)LEN)

46. Comparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: A randomised, crossover, open-label study

47. Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA(2)LEN)

48. P274 Comparison of the initiation of copd treatment with licensed fdc ics/laba treatments in terms of disease control and cost effectiveness

49. Dilemmas, Confusion, and Misconceptions Related to Small Airways Directed Therapy

50. Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting

Catalog

Books, media, physical & digital resources